Skip to main content

Research Program

Our Areas of Research

  • Timing of antiretroviral therapy and health outcomes in neonates and infants with HIV
  • Comorbidities among people growing up and aging with HIV
  • Molecular biomarkers of HIV, antiretroviral therapy, and aging with HIV
  • Inflammation and epigenetic mechanisms in perinatal epidemiology

 

Funding

  • PHACS Emerging Research Pilot Award (PI: Stephanie Shiau)
    Maternal ART, maternal inflammation, and epigenetic biomarkers in children with perinatal exposure to HIV
    Project Period: 05/01/2024 – 07/31/2025
  • NIH/NICHD R01HD111550 (PI: Stephanie Shiau)
    Maternal inflammation in relation to offspring epigenetic aging and neurodevelopment
    Project Period: 06/01/2023 – 05/31/2027
  • NIH/NIDA K01DA053157 (PI: Stephanie Shiau)
    Leveraging large-scale administrative claims data to evaluate prescription opioid use, risks, and outcomes in older adults living with HIV
    Project Period: 06/01/2021 – 04/30/2026
  • NIH/NIDCR (MPI: Modupe Coker and Stephanie Shiau)
    Uncovering the Biological Link between Oral and Mental health in Adolescents Living with HIV (uBLOoM)
    Project Period: 08/01/2023 – 07/31/2025
  • NIH/NICHD R21HD104558 (PI: Stephanie Shiau)
    Leveraging NICHD DASH biospecimens to isolate the effects of HIV infection and HIV exposure on epigenetic profiles in infants
    Project Period: 09/21/2020 – 08/31/2023 (NCE)